Read twice and referred to the Committee on Finance.
The bill amends the Medicare Secondary Payer provisions to clarify that group health plans may not discriminate against individuals with end-stage renal disease (ESRD) or treat dialysis less favorably than other covered services.
It prohibits benefit differentiations or limitations that disparately affect ESRD patients, while clarifying plans are not required to include specific dialysis providers in their networks.
The Secretary is directed to enforce these rules consistent with existing nonconformance determination requirements (part 411 of 42 C.F.R.).
Targeted, administrable change with modest fiscal effect raises plausibility, but insurer opposition and Senate procedure are key barriers.
Relative to its intended legislative type, this bill is a narrowly targeted substantive amendment that clearly states its purposes and inserts concrete prohibitory language into the Social Security Act, while relying on existing regulatory enforcement frameworks.
Lib-left emphasizes patient protections and anti-discrimination
Lib-left emphasizes patient protections and anti-discrimination
Likely strongly supportive: the bill protects a medically vulnerable population from discriminatory plan designs and prevents insurers from shifting costs to Medicare.
It affirms Congressional intent and closes loopholes that could let plans carve out or limit dialysis coverage.
Supporters would want robust enforcement and monitoring.
Cautiously supportive: the bill addresses a clear fairness concern for ESRD patients but raises predictable tradeoffs on cost and plan flexibility.
A moderate would back protections while seeking cost estimates, clearer enforcement procedures, and guardrails to limit unintended consequences.
Likely opposed or skeptical: views the bill as federal micromanagement of private plan design that could raise insurance costs and employer burdens.
Although it preserves network-selection rights, conservatives may see expanded enforcement and vague disparate-effect standards as overreach.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Targeted, administrable change with modest fiscal effect raises plausibility, but insurer opposition and Senate procedure are key barriers.
The bill has not accumulated any surfaced votes yet.
Lib-left emphasizes patient protections and anti-discrimination
Targeted, administrable change with modest fiscal effect raises plausibility, but insurer opposition and Senate procedure are key barriers.
Relative to its intended legislative type, this bill is a narrowly targeted substantive amendment that clearly states its purposes and inserts concrete prohibitory language into the Social Security Act, while relying on…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.